We are live on ! Find out more
ATYR

aTyr Pharma
ATYR

49 hedge funds and large institutions have $50.5M invested in aTyr Pharma in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

2% less funds holding

Funds holding: 50 → 49 (-1)

10% less capital invested

Capital invested by funds: $55.8M → $50.5M (-$5.33M)

Holders
49
Holders Change
-1
Holders Change %
-2%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
16
Reduced
11
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.53M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$1.14M
3
BIT
BlackRock Institutional Trust
California
+$869K
4
BA
BlackRock Advisors
Delaware
+$806K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$797K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$8.42M
2
RIM
RS Investment Management
California
-$6.22M
3
GCM
Gruss Capital Management
New York
-$2.36M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.05M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIM
51
RS Investment Management
California
– -$6.22M -112,849 Closed
GCM
52
Gruss Capital Management
New York
– -$2.36M -42,857 Closed
T. Rowe Price Associates
53
T. Rowe Price Associates
Maryland
– -$2.05M -37,175 Closed
EC
54
EcoR1 Capital
California
– -$295K -5,354 Closed
State Street
55
State Street
Massachusetts
– -$270K -4,878 Closed
Northern Trust
56
Northern Trust
Illinois
– -$243K -4,408 Closed
AIM
57
Alambic Investment Management
California
– -$238K -4,314 Closed
GPP
58
Great Point Partners
Connecticut
– -$197K -3,565 Closed
Bank of New York Mellon
59
Bank of New York Mellon
New York
– -$143K -2,591 Closed
TCIM
60
TIAA CREF Investment Management
New York
– -$76K -1,385 Closed
Charles Schwab
61
Charles Schwab
California
– -$74K -1,330 Closed
TD Asset Management
62
TD Asset Management
Ontario, Canada
– -$56K -1,010 Closed
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
– -$51K -926 Closed
TA
64
Teachers Advisors
New York
– -$35K -632 Closed
AIG
65
American International Group
New York
– -$14K -253 Closed
SO
66
STRS Ohio
Ohio
– -$7K -136 Closed
Wells Fargo
67
Wells Fargo
California
– -$2K -33 Closed
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
– -$370 -7 Closed
1 2
3

ATYR Hedge Fund Activity: Q2 2016 in Review

49 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q2 2016, worth a combined $50.5M — down 9.6% from $55.8M a quarter earlier.

Fund positioning in ATYR was balanced in Q2 2016: 19 funds opened new positions, 19 closed out, 16 added to existing stakes and 11 trimmed.

The largest buyer was Alyeska Investment Group, adding an estimated $1.53M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $8.42M sold.

  • 49 institutional investors held aTyr Pharma (ATYR) as of Q2 2016, down from 50 in Q1 2016.
  • Funds reported $50.5M of aTyr Pharma stock for Q2 2016, down 9.6% quarter-over-quarter.
  • 19 funds opened new aTyr Pharma positions in Q2 2016 and 19 closed out, a net change of 0 holders.
  • The largest aTyr Pharma buyer in Q2 2016 was Alyeska Investment Group, an estimated $1.53M added.
  • The largest aTyr Pharma seller in Q2 2016 was Baker Bros. Advisors, an estimated $8.42M sold.

Based on aggregated 13F filings for Q2 2016.